Treating Bipolar Depression

Bipolar depression is treated differently from ordinary depression, mainly because antidepressants on their own can trigger mania. The medications with the strongest evidence are a handful of atypical antipsychotics plus lithium and lamotrigine, used alone or in combination, and the best results usually come when medication is paired with therapy and steady sleep. This guide sets out what the major guidelines (CANMAT/ISBD, the VA/DoD and NICE) recommend, how psychotherapy, light therapy and sleep fit in, and what happens when first options do not work.

When to get help now

Why bipolar depression needs its own plan

The depressive phase of bipolar disorder can look identical to major depression, but the treatment logic is different. NIMH notes that antidepressants are not used alone in bipolar disorder because of the risk of mania or rapid cycling, so treatment starts from medications with anti-manic or mood-stabilizing effects. For what bipolar depression looks like and how it differs from the lows of everyday life, see bipolar depression: symptoms and signs. For the antidepressant question in depth, see antidepressants in bipolar disorder.

Medication options the guidelines name

Guidelines agree more than they differ, but each ranks options a little differently. The names below are guideline positions, not a recommendation for any individual:

The FDA-approved options for bipolar depression are all atypical antipsychotics or combinations: quetiapine, lurasidone, cariprazine (bipolar I), lumateperone (bipolar I or II) and the olanzapine/fluoxetine combination. Our page on atypical antipsychotics in bipolar disorder lists the label details and side effects. Lamotrigine has a different role: its FDA approval is for maintenance, to delay future episodes, and it has to be started slowly because of rash risk; see lamotrigine for bipolar disorder. Lithium matters here too, partly because NIMH notes it can lower the risk of suicide; see lithium for bipolar disorder.

Is there a "best" medication for bipolar 2 or bipolar depression?

People search for the single best medication, and the honest answer is that guidelines name a short list rather than one winner. Choosing among them means weighing:

• Which type of bipolar disorder you have (only quetiapine is first-line for bipolar II depression under CANMAT/ISBD 2018, and only lumateperone carries an FDA label for bipolar II depression).
• What has helped or failed before, including in relatives.
• Side effects that matter most to you: sleepiness, weight and metabolic effects, restlessness.
• Other conditions, pregnancy plans, and the medications you already take.
• Whether you also need protection against mania, which changes the shortlist.

Most medications for bipolar depression take several weeks to show their full effect. Changing course too early, or stopping a mood stabilizer suddenly, can make things worse, so changes go through your prescriber.

Psychotherapy: more than an add-on

In the STEP-BD psychosocial trial, 293 outpatients with bipolar depression took medication plus either intensive psychotherapy (family-focused therapy, interpersonal and social rhythm therapy, or CBT, up to 30 sessions) or three sessions of collaborative care. A year later, 64.4% of the intensive-therapy group had recovered versus 51.5% of the brief-care group, and they recovered faster.

NIMH names IPSRT, family-focused therapy and CBT as effective alongside medication. NICE recommends a psychological intervention developed for bipolar disorder, or CBT, interpersonal therapy or behavioral couples therapy, for bipolar depression, and the VA/DoD suggests adding psychotherapy without preferring one type. Our page on therapy for bipolar disorder compares these approaches.

Light therapy: add-on only, with monitoring

Bright light therapy has real evidence in bipolar depression, but only in a specific setting. In a randomized trial, adults with bipolar I or II depression who were already taking stable anti-manic medication used midday bright light or a dim placebo light. At weeks 4–6, 68.2% of the bright-light group were in remission versus 22.2% of the placebo group, with no switches into mania. People with mixed symptoms, rapid cycling or hypomania were excluded.

The ISBD Chronobiology Task Force (2025) called adjunctive bright light "likely an efficacious acute treatment for bipolar depression," said maintenance use is unproven, and recommended anti-manic medication (especially in bipolar I) and clinical monitoring. The VA/DoD likewise suggests short-term light therapy as an add-on to medication. In practice that means: do not buy a light box and start on your own. Timing, duration and who should avoid it are decisions for your prescriber.

Sleep and daily rhythm

Sleep is both a symptom and a lever. Depression may bring oversleeping or broken sleep, and short sleep can be an early sign of a swing upward. NIMH notes that CBT adapted for insomnia can help in bipolar depression, and IPSRT is built around keeping regular times for waking, meals and sleep. Keeping a mood and sleep log helps you and your prescriber see patterns. See sleep and bipolar disorder for practical steps.

When first options do not work

If two or more well-tried options have not helped, the next step is usually a careful review: is the diagnosis right, were doses and durations adequate, are thyroid problems, substances or another condition getting in the way? After that, other treatments come into view. NIMH describes ECT as usually considered when other treatments have not worked or when a rapid response is needed, such as with high suicide risk or catatonia; TMS needs no anesthesia and carries little risk to memory, but NIMH notes it is "not as powerful as ECT."

Ketamine, esketamine, TMS and ECT are not offered at Willow & Stone; we refer when they're indicated.

At Willow & Stone

At Willow & Stone, Dr. Stacey Forbes, PMHNP-BC, provides outpatient, scheduled care that combines medication management with psychotherapy. Medication options are discussed at your evaluation, labs are ordered as needed, and if a higher level of care is needed, we help you find it. Willow & Stone is not an emergency service. Learn about bipolar disorder treatment at Willow & Stone, read the complete bipolar disorder guide, or book a consultation.

Common Questions

Sources & Further Reading

• Keramatian, Chithra & Yatham: The CANMAT and ISBD guidelines, summary and 2023 update of evidence (Focus, 2023)
• VA/DoD Clinical Practice Guideline for the Management of Bipolar Disorder (Version 2.0, 2023)
• NICE CG185: Bipolar disorder: assessment and management (last updated 2 Sept 2025)
• NIMH: Bipolar Disorder (NIH Pub. 25-MH-8088, 2025)
• Miklowitz et al.: Psychosocial treatments for bipolar depression, STEP-BD (Arch Gen Psychiatry, 2007)
• Geoffroy et al.: Light therapy for bipolar disorders, ISBD Chronobiology Task Force (2025)
• DailyMed: Caplyta (lumateperone) prescribing information (6/2025)

This article is general education, not a diagnosis or advice for your situation. Do not start, stop, or change a medication without talking to the clinician who prescribes it; stopping a mood stabilizer suddenly can trigger relapse.